Literature DB >> 26022120

DNA damage, lysosomal degradation and Bcl-xL deamidation in doxycycline- and minocycline-induced cell death in the K562 leukemic cell line.

Mona Fares1, Manuchehr Abedi-Valugerdi2, Moustapha Hassan3, Zuzana Potácová4.   

Abstract

We investigated mechanisms of cytotoxicity induced by doxycycline (doxy) and minocycline (mino) in the chronic myeloid leukemia K562 cell line. Doxy and mino induced cell death in exposure-dependent manner. While annexin V/propidium iodide staining was consistent with apoptosis, the morphological changes in Giemsa staining were more equivocal. A pancaspase inhibitor Z-VAD-FMK partially reverted cell death morphology, but concurrently completely prevented PARP cleavage. Mitochondrial involvement was detected as dissipation of mitochondrial membrane potential and cytochrome C release. DNA double strand breaks detected with γH2AX antibody and caspase-2 activation were found early after the treatment start, but caspase-3 activation was a late event. Decrement of Bcl-xL protein levels and electrophoretic shift of Bcl-xL molecule were induced by both drugs. Phosphorylation of Bcl-xL at serine 62 was ruled out. Similarly, Bcr/Abl tyrosine kinase levels were decreased. Lysosomal inhibitor chloroquine restored Bcl-xL and Bcr/Abl protein levels and inhibited caspase-3 activation. Thus, the cytotoxicity of doxy and mino in K562 cells is mediated by DNA damage, Bcl-xL deamidation and lysosomal degradation with activation of mitochondrial pathway of apoptosis.
Copyright © 2015 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Cell death; Doxycycline; K562 cell line; Minocycline

Mesh:

Substances:

Year:  2015        PMID: 26022120     DOI: 10.1016/j.bbrc.2015.05.043

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

Review 1.  Metabolic reprogramming by driver mutation-tumor microenvironment interplay in pancreatic cancer: new therapeutic targets.

Authors:  Henriette Berg Andersen; Renata Ialchina; Stine Falsig Pedersen; Dominika Czaplinska
Journal:  Cancer Metastasis Rev       Date:  2021-12-02       Impact factor: 9.264

2.  Fabrication, Characterization and Response Surface Method (RSM) Optimization for Tetracycline Photodegration by Bi3.84W0.16O6.24- graphene oxide (BWO-GO).

Authors:  Chengjie Song; Xinying Li; Liping Wang; Weidong Shi
Journal:  Sci Rep       Date:  2016-11-18       Impact factor: 4.379

3.  Doxycycline directly targets PAR1 to suppress tumor progression.

Authors:  Weilong Zhong; Shuang Chen; Qiang Zhang; Ting Xiao; Yuan Qin; Ju Gu; Bo Sun; Yanrong Liu; Xiangyan Jing; Xuejiao Hu; Peng Zhang; Honggang Zhou; Tao Sun; Cheng Yang
Journal:  Oncotarget       Date:  2017-03-07

4.  Anti-proliferative effect of Jesridonin on paclitaxel-resistant EC109 human esophageal carcinoma cells.

Authors:  Cong Wang; Liubin Guo; Saiqi Wang; Junwei Wang; Yongmei Li; Yinhui Dou; Ran Wang; Hongge Shi; Yu Ke; Hongmin Liu
Journal:  Int J Mol Med       Date:  2017-01-24       Impact factor: 4.101

5.  Special Thai Oolong Tea: Chemical Profile and In Vitro Antidiabetic Activities.

Authors:  Narawadee Rujanapun; Wuttichai Jaidee; Thidarat Duangyod; Pravaree Phuneerub; Napassawan Paojumroom; Tharakorn Maneerat; Chuchawal Pringpuangkeo; Salfarina Ramli; Rawiwan Charoensup
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.